REPLY.

We thank the correspondents for their interest in our study regarding the development of ABIDE, a predictive model of hepatic decompensation in non-alcoholic fatty liver disease (NAFLD) patients with cirrhosis. We have previously published outcomes in the derivation cohort(1), and appreciate the opportunity to clarify our data. Significant alcohol intake (>20 g/d for men, >10 g/d for women) during 2 years prior to enrolment or during follow-up was a standard exclusion,(1) and only two patients were taking vitamin E.